PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2020 April; 11(2): e0011. ISSN: 2076-9172Published online 2020 April 29. doi: 10.5041/RMMJ.10397.

Table 3.

Medications at Discharge.

Medication	All patients (n=293^*)	Microcytic Anemia (n=50)	Normocytic Anemia (n=226^*)	Macrocytic Anemia (n=17)	P Value
Aspirin, n (%)	290 (99.0%)	50 (100.0%)	224 (99.1%)	16 (94.1%)	0.104
Aspirin monotherapy, n (%)	28 (9.6%)	5 (10.0%)	21 (9.3%)	2 (11.8%)	0.981
P2Y₁₂ receptor inhibitor, n (%)	263 (89.7%)	45 (90.0%)	203 (89.8%)	15 (88.2%)	0.977
Oral anticoagulation, n (%)	19 (6.5%)	1 (2.0%)	15 (6.6%)	3 (17.7%)	0.076
Warfarin, n (%)	16 (5.5%)	1 (2.0%)	12 (5.3%)	3 (17.7%)	0.048
Novel oral anticoagulants, n (%)	3 (1.0%)	0 (0.0%)	3 (1.3%)	0 (0.0%)	0.550
Triple therapy, n (%)	11 (3.8%)	1 (2.0%)	9 (4.0%)	1 (5.9%)	0.715

^*One patient died during index hospitalization.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2020 April; 11(2): e0011. ISSN: 2076-9172

Published online 2020 April 29. doi: 10.5041/RMMJ.10397